v3.24.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Cash from operating activities:    
Net loss $ (11,241,718) $ (6,864,783)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 550,201 350,192
Stock based compensation 710,047 819,191
Stock issued for services 143,065 157,500
Amortization of operating lease right of use asset 316,776 235,834
Changes in assets and liabilities:    
   Accounts receivable 1,955,800 (1,679,720)
   Note receivable (153,750)
   Contract assets (216,225) (422,273)
   Inventory (97,804) (1,130,022)
   Security deposit 50,000
   Prepaid expenses and other current assets 744,771 266,539
   Accounts payable (1,694,756) 1,245,890
   Accrued expenses (289,209) (165,069)
   Operating lease obligation (232,007) 184,728
   Contract liabilities 708,245 (871,314)
Net cash used in operating activities (8,746,564) (7,873,307)
Cash flows from investing activities:    
    Purchase of patents/trademarks (69,327) (18,190)
    Purchase of software development (527,896) (281,783)
    Purchase of fixed assets (496,686) (344,915)
Net cash used in investing activities (1,093,909) (644,888)
Cash flows from financing activities:    
   Repayments of insurance and equipment financing (520,529) (331,175)
   Repayment of finance lease (22,851) (80,335)
   Proceeds from common stock issued 8,801,003
   Issuance cost (25,797) (942,926)
   Proceeds from shares issued under Employee Stock Purchase Plan 230,400
   Proceeds from preferred stock issued 11,500,000 1,299,000
Net cash provided by financing activities 11,161,223 8,745,567
Net increase in cash 1,320,750 227,372
Cash, beginning of year 1,121,092 893,720
Cash, end of year 2,441,842 1,121,092
Supplemental Disclosure of Cash Flow Information:    
Interest paid 7,159 9,292
Taxes paid 29,085 1,264
Supplemental Non-Cash Investing and Financing Activities:    
Notes issued for financing of insurance premiums $ 487,929 $ 353,244

Source